NCCN 2012 Congress Series: Lung Cancers™
This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This Congress will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
There is a $49 fee for this educational activity for health care providers. There is a $495 fee for industry attendees.
Target Audience
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Learning Objectives
Following this congress, participants should be able to:
Non-Small Cell Lung Cancer
- Describe the appropriate treatment strategies for patients with localized Non-Small Cell Lung Cancer
- Select the most appropriate therapy for patients with advanced Non-Small Cell Lung Cancer based on specific criteria (e.g., histology)
- Describe the role of maintenance therapy in Non-Small Cell Lung Cancer
- Describe newer radiation therapy techniques for patients with Non-Small Cell Lung Cancer (e.g., SBRT, image-guided radiation therapy)
Small Cell Lung Cancer
- Provide examples of appropriate treatment regimens for patients with extensive stage Small Cell Lung Cancer
- Discuss the role of surgical therapy in the management of Small Cell Lung Cancer
Palliative Care
- Summarize the most common and severe symptoms of lung cancer and its treatment that often require palliative care
- Explain some of the palliative therapies for the most common and severe lung cancer symptoms, such as dyspnea, airway obstruction, and hemoptysis
Agenda
7:15 – 8:00 AM
Registration
8:00 – 8:10 AM
Welcome
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute
NON-SMALL CELL LUNG CANCER
8:10 – 8:55 AM
Surgical Issues in Local Disease
Andrew C. Chang, MD
University of Michigan Comprehensive Cancer Center
9:00 – 9:45 AM
Adjuvant Therapy of Non-Small Cell Lung Cancer
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute
9:45 – 10:05 AM
Break
10:05 – 10:50 AM
Use of Radiation Therapy in Non-Small Cell Lung Cancer
Billy W. Loo, Jr., MD, PhD
Stanford Cancer Institute
10:55 – 11:40 AM
Metastatic Disease of Non-Small Cell Lung Cancer
Renato Martins, MD, MPH
Seattle Cancer Care Alliance
11:40 AM – 12:40 PM
Lunch
SMALL CELL LUNG CANCER
12:40 – 1:40 PM
Management of Extensive-Stage Disease
Gregory P. Kalemkerian, MD
University of Michigan Comprehensive Cancer Center
1:45 – 2:30 PM
Surgical Issues in Small Cell Lung Cancer
Robert J. Downey, MD
Memorial Sloan-Kettering Cancer Center
PALLIATIVE CARE
2:35 – 3:20 PM
Palliative Care in Lung Cancer
Michael H. Levy, MD, PhD
Fox Chase Cancer Center
3:20 – 3:30 PM
Closing Remarks
Speakers subject to change based on availability.
Available Credit
- 5.50 Participation
- 5.50 Nurse
- 5.50 Pharmacist
- 5.50 Physician